Armistice Capital »

HudBay Minerals shares owned by Armistice Capital

Quarter-by-quarter ownership of HudBay Minerals (HBM) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in HudBay Minerals

Tip: Access up to 7 years of quarterly data

All positions including HudBay Minerals held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in HudBay Minerals by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $98k 11k 9.05

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding HudBay Minerals

Vanguard Group
L1 Capital Pty
Mirae Asset Global Etfs Holdings
Invesco
Letko, Brosseau & Associates
Connor, Clark & Lunn Investment Management
Waratah Capital Advisors
Morgan Stanley
Royal Bank of Canada
Edgepoint Investment
Condire Management
Mackenzie Financial
Dimensional Fund Advisors
T. Rowe Price Investment Management
Donald Smith & Co

View all funds holding HudBay Minerals